Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease.

Kong-Xiang ZhuPei-Yuan Songnull He-LiMu-Peng LiYin-Xiao DuQi-Lin MaLi-Ming PengXiao-Ping Chen

Published in: European journal of clinical pharmacology (2020)

The FMO3 rs1736557 AA genotype was related to an increased the antiplatelet potency of clopidogrel in Chinese CAD patients. Additional studies are required to verify this finding.

Keyphrases

acute coronary syndrome
end stage renal disease
percutaneous coronary intervention
newly diagnosed
chronic kidney disease
ejection fraction
antiplatelet therapy
coronary artery disease
prognostic factors
patient reported outcomes